News

The expanded organization provides the biopharmaceutical industry with access to a global CRO that has its focus on the developmental phase between intellectual property (IP) and submission of

According to Cempra Pharma, CEM-101 is expected to be the first macrolide to have an intravenous formulation available in the US since intravenous azithromycin was approved in 1997,

GlycosBio has created a platform that can consume carbon from multiple non-sugar feedstock sources to produce a variety of chemical products. The approach not only eliminates the risk

GeNO said that the initial indication to be studied for nitric oxide delivered via the GeNO Nitrosyl delivery system is as a diagnostic agent for administration as an

The company is the maker of Vagisil brand feminine hygiene products and had been marketing Vagisil deodorant powder in a 7-oz bottle size. The company intended to come

Orphan-drug designation will be granted by the FDA Office of Orphan Drug Products Development to novel drugs or biologics that may treat a condition affecting less than 200,000

According to the agreement, Omeros is responsible for clinical and commercial milestone payments to Asubio. Omeros would also pay a single-digit royalty to Asubio upon potential sale of

Ms Hancook, most recently a short-term consultant and contractor, will join Viachem from Intervoice/Convergys where she was director of worldwide corporate communications. She has also headed marketing, business

Takeda Pharma North America will start marketing the drug under the new name in late April 2010. After Kapidex was approved in January 2009, there have been reports